Please refer to the attached annexure.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kothari Fermentation & Biochem Ltd reported Q3 FY26 revenue from operations of Rs 3,194.97 lakhs, up ~4.6% from Rs 3,053.03 lakhs in Q3 FY25. However, nine-month revenue declined ~2.9% YoY to Rs 7,966.39 lakhs (from Rs 8,205.23 lakhs). The company swung to a net loss of Rs 37.84 lakhs in Q3 FY26, compared to a profit of Rs 41.09 lakhs in the year-ago quarter. Nine-month losses widened sharply to Rs 458.03 lakhs (vs loss of Rs 24.13 lakhs in 9M FY25). EBITDA margin compressed materially - Q3 margin fell from ~10.4% to ~7.5%, and 9M margin from ~9.2% to ~4.5%. No exceptional items were reported. The board also approved an amendment to the Related Party Transactions Policy.
Widening losses and significant margin compression signal operational stress and are negative for shareholders. The stock may face pressure given the deteriorating profitability, though the YoY Q3 revenue uptick provides some mild encouragement.